U.S. Healthcare Services Stock News

What recent performance tells you about Pulse Biosciences stock Pulse Biosciences (PLSE) has drawn attention after a period of strong share price moves, with the stock up about 24% over the past month and about 34% over the past 3 months. For context, the Miami based bioelectric medicine company has a market value of about US$1.71b and focuses on its nPulse system platform across dermatology and cardiac applications, an area many investors track closely in the healthcare segment. See our...

Earlier this year, Griffon reported Q1 revenue of US$421.9 million, a 1.1% decline from a year earlier but slightly ahead of analyst forecasts, while updating full-year revenue and EBITDA guidance to levels below market expectations. This weaker outlook stood in contrast to generally stronger guidance and results across the broader home construction materials group, highlighting company-specific challenges despite a resilient sector backdrop. Now we’ll examine how Griffon’s softer full-year...

General Motors recently announced that director Jonathan McNeill will retire from its Board after the 2026 Annual Meeting, while Pinnacle Intelligence has been approved as an authorized vendor for Business Development Center services to help improve dealership operations using data, AI, and a global workforce. Together with Gentherm’s recognition as a 2025 Supplier of the Year, these developments highlight General Motors’ focus on strengthening its ecosystem across suppliers, technology...

Earlier in May, Broadridge Financial Solutions closed a US$500 million offering of 5.750% senior notes due 2036 to help repay its 3.400% senior notes due 2026, and separately declared a quarterly dividend of US$0.9750 per share payable on July 2, 2026. Broadridge also expanded its long-running partnership with Kyndryl to modernize core infrastructure with AI-enabled operations and quantum-safe capabilities, aiming to enhance resilience, security, and support for its digitized investing and...

Ameresco (AMRC) has just finished the first phase of a multi year manhole rehabilitation project with the City of Mesquite, Texas, refurbishing more than 190 aging structures in the city’s wastewater system. See our latest analysis for Ameresco. Ameresco’s recent wastewater win and investor conference appearances come as momentum in the stock has picked up, with a 30 day share price return of 31.84% and a 1 year total shareholder return of 161.1%, even though the 3 and 5 year total...

Black Stone Minerals (BSM) has attracted fresh attention after recent trading left the stock at $13.56, with performance mixed over the past week, month, and past 3 months while longer term returns remain positive. See our latest analysis for Black Stone Minerals. Recent trading has been choppy, with the share price down 10.20% over the past 90 days but supported by an 11.05% 1-year total shareholder return and a 124.51% 5-year total shareholder return, suggesting longer term momentum remains...

Wondering whether Sea at US$90.53 is a bargain or still pricing in a lot of hope? This article breaks down what the current share price might be implying. The stock has risen 3.7% over the past week and 8.8% over the past month. It is still down 31.2% year to date and has declined 43.5% over the last year, which naturally raises questions about how to think about risk and potential reward. Across the last few years investors have reacted to shifting expectations for Sea's key businesses. The...

Nextpower (NasdaqGS:NXT) has entered a definitive agreement to acquire Prevalon Energy. The deal expands Nextpower beyond solar hardware into battery energy storage systems and intelligent energy management software. The acquisition targets critical infrastructure customers, including AI data centers and utilities. Nextpower, trading at $156.51, has seen sharp share price moves recently, with the stock up 19.9% over the past week and 37.0% over the past month. Returns of 68.7% year to date...

If you are wondering whether Nucor stock still offers value at current levels, the key is understanding what the recent share price is actually pricing in. The stock last closed at US$250.00, with returns of 7.8% over 7 days, 12.4% over 30 days, 47.6% year to date and 132.1% over 1 year. This naturally raises questions about how much upside or downside may be left. Recent coverage of Nucor has focused on its position within the broader materials sector and how investor sentiment around steel...

In May 2026, Personalis, Inc. announced that CMS’s Molecular Diagnostic Services Program expanded Medicare coverage for its NeXT Personal minimal residual disease test to include monitoring neoadjuvant therapy response in Stage II–III triple-negative and HER2-positive breast cancer patients. This decision, supported by the PREDICT-DNA study showing the value of ultrasensitive ctDNA monitoring below 100 parts per million, broadens NeXT Personal’s clinical role in guiding treatment before...

Bank of America (NYSE:BAC) is extending its multi year Community Homeownership Commitment, which has provided over $15b in affordable home loans and $600m in down payment assistance to more than 57,000 buyers. The bank is also funding three arts conservation initiatives in Canada, including major restoration projects and sponsorship of a conservation conference. These programs focus on housing affordability and cultural preservation, reinforcing Bank of America’s social impact agenda. Bank...

State Street plans to close and liquidate the State Street DoubleLine Emerging Markets Fixed Income ETF (EMTL). Final trading in EMTL is expected to occur in July 2026, after which the fund will be liquidated. The decision affects existing EMTL shareholders and adds a fresh data point to how State Street manages its ETF lineup. For investors watching State Street (NYSE:STT), this move comes as the stock trades at $155.64, with a reported return of 20.6% year to date and 66.2% over the past...

Board moves and dividend change put Lennox International (LII) in focus Lennox International (LII) is back on investors’ radar after a quarterly report that beat revenue expectations, a higher quarterly dividend, and a board reshuffle that reduced director seats from nine to eight. See our latest analysis for Lennox International. Lennox International’s recent revenue beat, dividend increase and board changes come after a mixed period for the stock. The share price is down about 12% over...

Marsh & McLennan Companies (MRSH) stock has been under pressure recently, with shares down about 6% over the past month and roughly 14% over the past 3 months, prompting closer investor attention. See our latest analysis for Marsh & McLennan Companies. Zooming out, the 30 day share price return of down 6.4% and 90 day share price return of down 14.3% sit against a 1 year total shareholder return decline of 30.2%. This suggests momentum has been fading recently. If you are reassessing your...

ePlus (PLUS) closed out FY 2026 with fourth quarter revenue of US$581.6 million and basic EPS of US$0.97, setting the stage for investors to reassess how the business is trending into the new year. The company has seen quarterly revenue move from US$498.1 million in Q4 FY 2025 to US$581.6 million in Q4 FY 2026, while basic EPS in those periods came in at US$0.96 and US$0.97 respectively. Over the last 12 months, net income excluding extra items totaled US$124.1 million on revenue of US$2.4...

Wondering if NetApp at US$174.29 is still offering value after a strong run, or if expectations have already been priced in? This article focuses squarely on what the current share price implies. The stock has posted returns of 25.1% over the past week, 60.4% over the past month, 63.7% year to date and 79.2% over the last year, with longer term figures of 161.3% over three years and 142.6% over five years that many investors will want to put into context. Recent market conversation around...

Wondering if BNY is still worth a closer look after its run, or if most of the value is already reflected in the share price? This article breaks down what the current price might be implying. Bank of New York Mellon Corporation's stock recently closed at US$139.43, with returns of 0.2% over 7 days, 5.4% over 30 days, 19.1% year to date and 60.3% over the last year. The 3 year return is around 3x and the 5 year return is just over 2x. Recent headlines around BNY have focused on its role as a...

Earlier this week, Stifel analyst Jeffrey Stantial outlined how Churchill Downs could unlock value by selling or spinning off its slower-growth gaming segment, highlighting options ranging from one-off asset sales to a full tax-free spin-off. This analyst-driven discussion puts a spotlight on the company’s portfolio mix, raising questions about whether separating gaming from core racing and online wagering could reshape how investors view the business. We’ll now examine how the potential...

Universal (NYSE:UVV) FY 2026 Earnings Snapshot Universal (NYSE:UVV) closed out FY 2026 with Q4 revenue of US$715.2 million and a reported loss per share of US$1.73, as investors weighed these headline figures against full year trends. Over the past six quarters, revenue has moved between US$593.8 million and US$937.2 million per quarter, while quarterly EPS ranged from US$0.34 to US$2.39 before this latest loss. This gives you a wide band of outcomes to factor into your view on the stock...

Wondering whether Huntington Ingalls Industries, at around US$308 a share, still offers value or if most of the opportunity has already been priced in. The stock is down 3.9% over the past week and 14.9% over the past month, yet it still shows a 40.5% return over 1 year and 58.2% over 3 years, which can change how you think about both risk and opportunity. Recent coverage has focused on Huntington Ingalls Industries as a key US defense contractor, with attention on its role in major long...

Q1 2027 earnings set the stage Okta (OKTA) has just opened Q1 2027 with revenue of US$765 million and basic EPS of US$0.42, putting fresh numbers behind a year in which trailing EPS reached US$1.40 on US$3.0 billion of revenue and net income of US$247 million. Over the past six reported quarters, revenue has moved from US$682 million in Q4 2025 to US$765 million in Q1 2027, while quarterly basic EPS has ranged between US$0.13 and US$0.42. This gives investors a clearer picture of how profit...

Wondering if Eastman Chemical at around US$75.87 is offering real value or just fair pricing? This article walks through what the numbers say about the stock. The share price return sits at 2.4% over the past week, 7.7% over the past month, 17.9% year to date and 1.6% over the past year, against a longer-term picture that includes a 3.5% return over three years and a decline of 29.7% over five years. Recent coverage has focused on Eastman Chemical's role as a diversified materials producer,...

Wondering whether Coursera at US$5.39 is starting to look like value, or if the stock still carries more risk than reward. The share price has inched up about 1.3% over the last week, but is still down about 11.8% over the past month, 23.9% year to date and 39.1% over the last year, which may catch the eye of investors looking for a reset opportunity. Recent headlines have focused on Coursera's position as a major online learning platform and its role in digital upskilling partnerships. This...

Earlier in 2026, Tenet Healthcare reported a strong Q1 with a sharp jump in net income, double-digit Ambulatory Care revenue growth and reaffirmed full-year adjusted EBITDA guidance, supported by healthy cash generation and capital returns. An important angle for investors is how Tenet’s expansion of its Ambulatory Care network and the restructuring of its CommonSpirit Health contract could reshape the mix and resilience of its earnings over time. Next, we’ll examine how Tenet’s reaffirmed...